BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37527887)

  • 1. Patient-reported, health economic and psychosocial outcomes in patients with Friedreich ataxia (PROFA): protocol of an observational study using momentary data assessments via mobile health app.
    Buchholz M; Weber N; Borel S; Sayah S; Xie F; Schulz JB; Reetz K; Boesch S; Klopstock T; Karin I; Schöls L; Grobe-Einsler M; Klockgether T; Davies EH; Schmeder M; Nadke A; Michalowsky B
    BMJ Open; 2023 Aug; 13(8):e075736. PubMed ID: 37527887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer.
    Ciani O; Cucciniello M; Petracca F; Apolone G; Merlini G; Novello S; Pedrazzoli P; Zilembo N; Broglia C; Capelletto E; Garassino M; Nicod E; Tarricone R
    BMJ Open; 2019 Feb; 9(2):e025483. PubMed ID: 30772862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes.
    Vogel AP; Folker J; Poole ML
    Cochrane Database Syst Rev; 2014 Oct; (10):CD008953. PubMed ID: 25348587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of disease prevalence, health-related quality of life, and economic outcomes associated with Friedreich's Ataxia.
    Buesch K; Zhang R
    Curr Med Res Opin; 2022 Oct; 38(10):1739-1749. PubMed ID: 35983717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled trial using a theory-based m-health intervention to improve physical activity and sleep health in adults: the Synergy Study protocol.
    Murawski B; Plotnikoff RC; Rayward AT; Vandelanotte C; Brown WJ; Duncan MJ
    BMJ Open; 2018 Feb; 8(2):e018997. PubMed ID: 29439005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Digital Marshmallow Test (DMT) Diagnostic and Monitoring Mobile Health App for Impulsive Behavior: Development and Validation Study.
    Sobolev M; Vitale R; Wen H; Kizer J; Leeman R; Pollak JP; Baumel A; Vadhan NP; Estrin D; Muench F
    JMIR Mhealth Uhealth; 2021 Jan; 9(1):e25018. PubMed ID: 33480854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatments for Friedreich ataxia.
    Kearney M; Orrell RW; Fahey M; Brassington R; Pandolfo M
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD007791. PubMed ID: 27572719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Electronic Patient-Reported Outcome Mobile App for Data Collection in Type A Hemophilia: Design and Usability Study.
    Petracca F; Tempre R; Cucciniello M; Ciani O; Pompeo E; Sannino L; Lovato V; Castaman G; Ghirardini A; Tarricone R
    JMIR Form Res; 2021 Dec; 5(12):e25071. PubMed ID: 34855619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality Of Life
    Younger E; Jones RL; Desar IME; Peckitt C; van der Graaf WTA; Husson O
    BMJ Open; 2020 Jun; 10(6):e035171. PubMed ID: 32487574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.
    Alonso-Solís A; Rubinstein K; Corripio I; Jaaskelainen E; Seppälä A; Vella VA; Caro-Mendivelso J; Caspi A; Isohanni M; Unoka Z; Van der Graff S; Farkas K; Huerta-Ramos E; Marcó-García S; Stevens M; Coenen T; Hospedales M; Berdún J; ; Grasa EM
    BMJ Open; 2018 Jul; 8(7):e021346. PubMed ID: 30012788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural and patient-individual determinants of quality of life, functioning and physical activity in older adults (MobilE-TRA 2): study protocol of an observational cohort study in a tertiary care setting.
    Katzenberger B; Schwettmann L; Weigl M; Paulus A; Pedron S; Fuchs S; Koller D; Grill E
    BMJ Open; 2021 Dec; 11(12):e051915. PubMed ID: 34887277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing Internet-based psychotherapy for adults with emotional disorders using ecological momentary assessments and interventions: Study protocol of a feasibility trial with "My EMI, Emotional Well-being" app.
    Gual-Montolio P; Suso-Ribera C; García-Palacios A; Castilla D; Zaragoza I; Bretón-López J
    Internet Interv; 2023 Mar; 31():100601. PubMed ID: 36686334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.
    Reetz K; Dogan I; Hilgers RD; Giunti P; Mariotti C; Durr A; Boesch S; Klopstock T; de Rivera FJR; Schöls L; Klockgether T; Bürk K; Rai M; Pandolfo M; Schulz JB;
    Lancet Neurol; 2016 Dec; 15(13):1346-1354. PubMed ID: 27839651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational non-randomised controlled evaluation of the effectiveness of cancer counselling centres: a study protocol.
    Lingens SP; Schilling G; Harms J; Schulz H; Bleich C
    BMJ Open; 2019 Dec; 9(12):e032889. PubMed ID: 31806615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT).
    Herrett E; Tomlin K; Lin LY; Tomlinson LA; Jit M; Briggs A; Marks M; Sandmann F; Parry J; Bates C; Morley J; Bacon S; Butler-Cole B; Mahalingasivam V; Dennison A; Smith D; Gabriel E; Mehrkar A; Goldacre B; Smeeth L; Eggo RMM
    BMJ Open; 2023 Feb; 13(2):e071261. PubMed ID: 36806073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Framework to assess the quality of mHealth apps: a mixed-method international case study protocol.
    Tan YY; Woulfe F; Chirambo GB; Henn P; Cilliers L; Fadahunsi KP; Taylor-Robinson SD; O'Donoghue J
    BMJ Open; 2022 Oct; 12(10):e062909. PubMed ID: 36307160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving chronic pain management with eHealth and mHealth: study protocol for a randomised controlled trial.
    Jaén I; Suso-Ribera C; Castilla D; Zaragoza I; García-Palacios A; Gómez Palones JL
    BMJ Open; 2019 Dec; 9(12):e033586. PubMed ID: 31888939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol for a prospective, double-blinded, observational study investigating the diagnostic accuracy of an app-based diagnostic health care application in an emergency room setting: the eRadaR trial.
    Faqar-Uz-Zaman SF; Filmann N; Mahkovic D; von Wagner M; Detemble C; Kippke U; Marschall U; Anantharajah L; Baumartz P; Sobotta P; Bechstein WO; Schnitzbauer AA
    BMJ Open; 2021 Jan; 11(1):e041396. PubMed ID: 33419909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.